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Legionella pneumophila (Lp) is commonly found in freshwater habitats but is also the causative agent 
of Legionnaires' disease when infecting humans. Although various virulence factors have been 
reported, little is known about the nutrition and the metabolism of the bacterium. Here, we report the 
application of isotopologue profiling for analyzing the metabolism of L. pneumophila. Cultures of Lp 






C2]glucose. After growth, 
13
C enrichments 
and isotopologue patterns of protein-derived amino acids and poly-3-hydroxybutyrate were determined 
by mass spectrometry and/or NMR spectroscopy. The labeling patterns detected in the experiment 
with [U-
13
C3]serine showed major carbon flux from serine to pyruvate and from pyruvate to acetyl-CoA, 
which serves as a precursor of poly-3-hydroxybutyrate or as a substrate of a complete citrate cycle 
with Si specificity of the citrate synthase. Minor carbon flux was observed between pyruvate and 
oxaloacetate/malate by carboxylation and decarboxylation, respectively. The apparent lack of label in 
Val, Ile, Leu, Pro, Phe, Met, Arg, and Tyr confirmed that L. pneumophila is auxotrophic for these amino 
acids. Experiments with [
13
C]glucose showed that the carbohydrate is also used as a substrate to feed 
the central metabolism. The specific labeling patterns due to [1,2-
13
C2]glucose identified the Entner-
Doudoroff pathway as the predominant route for glucose utilization. In line with these observations, a 
mutant lacking glucose-6-phosphate dehydrogenase (Δzwf) did not incorporate label from glucose at 
significant levels and was slowly outcompeted by the wild type strain in successive rounds of infection 
in Acanthamoeba castellanii, indicating the importance of this enzyme and of carbohydrate usage in 







Lp   Legionella pneumophila 
PHB   poly-3-hydroxybutyrate 
EMP   Embden-Meyerhof-Parnas 
ED   Entner-Doudoroff 
GC/MS   gas chromatography/mass spectrometry 
PP   pentose phosphate 
AYE   ACES-buffered yeast extract 
ACES   2-[(2-amino-2-oxoethyl)amino]ethanesulfonic acid 
BCYE   buffered charcoal-yeast extract 
CDM   chemically defined medium 
CFU   colony forming unit(s) 
RT   reverse transcriptase 
TBDMS  tert-butyldimethylsilyl 





The Gram-negative bacterium Legionella pneumophila (Lp)
5
 can be found in freshwater habitats 
where it replicates within protozoa, mainly amoebae such as Acanthamoeba castellanii. Lp can also 
be transmitted to humans by contaminated aerosols. After entering the human lung, the pathogen is 
phagocytosed by alveolar macrophages wherein it is able to replicate, leading to Legionnaires‘ 
disease, an atypical pneumonia.  
Lp survives within amoebae and macrophages because of its ability to establish a replication vacuole 
that is derived from the endoplasmic reticulum. Once within a vacuole, Lp differentiates into the 
replicative form. When nutrients become limiting, a regulatory cascade triggers the differentiation to a 
spore-like mature intracellular form (MIF), the so-called transmissive form, which metabolically seems 
to be nearly dormant (1,–,6). These forms exhibit a thickened cell wall and high amounts of 
cytoplasmic granules of poly-3-hydroxybutyrate (PHB), a general energy and carbon storage 
compound of bacteria (1, 7, 8). When released from spent hosts, these transmissive forms of Lp are 
able to persist for long periods in the environment. It has also been shown that Lp is able to 
differentiate into a “viable but nonculturable” status of greatly reduced metabolic activity after 
persistence in water (9). Notably, Legionella species can also grow in defined culture media under 
laboratory conditions (10,–,15). However, less is known about the routes of nutrient utilization during 
growth in culture media as well as during intracellular multiplication (16,–,20).  
Legionella exhibits a strictly respiratory form of metabolism and does not grow anaerobically (18). The 
amino acids Arg, Ile, Leu, Val, Met, Ser, and Thr are reportedly essential for growth of Lp in culture 
(10,–,12, 14, 15, 21,–,23), whereas a partial requirement for Cys (or cystine) has also been observed 
(24). It is also well known that Lp uses amino acids as preferred energy and carbon sources (4, 10,–
,12, 14, 21, 22). More specifically, Ser, Glu, Tyr, and/or Thr are efficiently used as carbon and energy 
sources in vitro (14), and Cys, Gln, Ser, and Arg support growth in vivo (19). From in silico analysis of 
the known Lp genome sequences it is proposed that Lp is auxotrophic for the amino acids Cys, Met, 
Arg, Thr, Val, Ile, and Leu (18, 25, 26). Therefore, it is not surprising that Lp harbors genes for ∼12 
classes of ABC (ATP-binding cassette) transporters and amino acid permeases, as well as various 
different amino peptidases and proteases. In addition, it has been shown that amino acid transporters 
of the host cell and of Lp are essential for intracellular replication; specifically, a neutral amino acid 
transporter of the host cell (SLC1A5 of MM6 monocyte cells) is necessary for Lp to replicate within this 
host (19). Furthermore, a bacterial Thr transporter (PhtA) is reported to be essential for replication of 
Lp in bone marrow-derived macrophages from mice (27).  
  
In earlier studies, it was also suggested that Lp is able to use glucose as a carbon source (14, 15, 20), 
although the addition of glucose to the medium did not support in vitro growth (18, 20). As no active 
sugar transport could be demonstrated in vitro (14, 16, 18), it is generally believed that Lp does not 
utilize sugars as a carbon source but relies on gluconeogenesis (18). On the other hand, some of the 
various ABC-type transport systems might be involved in sugar uptake, because Lp also possesses 
putative systems for degradation of cellulose, chitin, starch, and glycogen (28). Recently, Lp has been 
shown to actively degrade cellulose (29). On the basis of this evidence it can be assumed that glucose 
is also catabolized, but the metabolic routes are still unknown.  
The four sequenced genomes of Lp (Lp Philadelphia (26), Lp Paris, Lp Lens (25), and Lp Corby (30) 
indicate the presence of the Embden-Meyerhof-Parnas (EMP) pathway as well as the Entner-
Doudoroff (ED) pathway. However, in vitro enzyme assays did not detect activities for the ED pathway 
in strains Knoxville-1 and Philadelphia-1 (17, 20). Genes encoding the pentose phosphate (PP) 
pathway are also present, with the exception of 6-phosphogluconate dehydrogenase and the 
transaldolase (16, 18, 25, 26).  
As the activity of pyruvate dehydrogenase was low in cell-free extracts (17, 20), it was hypothesized 
that the bulk of the acetyl-CoA entering the citrate cycle or used as precursor for the storage 
compound PHB is derived from fatty acid catabolism (18). Indeed, Lp possesses huge amounts of 
phospholipases exerting extracellular and cell-associated activities (31,–,33). However, the glyoxylate 
shunt appears to be absent in the Lp strains sequenced thus far.  
One powerful method of studying metabolic pathways in growing microbes is based on incorporation 
experiments with stable isotope-labeled precursors (e.g. 
13
C-labeled glucose) followed by the 
determination of the resulting isotopologue patterns in key metabolites, such as protein-derived amino 
acids or other storage compounds. Using stoichiometric models, isotopologue profiles can serve as 
constraints in metabolic flux calculations (
13
C-based metabolic flux analysis) (34). Metabolic flux 
analysis is now well established for the analysis of metabolic flux in microorganisms growing under 
standardized conditions (reviewed in Refs. 34 and 35). These models typically rely on the use of 
minimal media with only one possible carbon source. It is therefore difficult to adapt metabolic flux 
analysis calculations to organisms with complex multiple carbon usage (i.e. when growing in complex 
media). However, because of the specificity of the detected isotopologue profiles, observation-driven 
analysis can also trace metabolic pathways in cases with unknown and/or multiple carbon usage (36, 










Strains, Growth Conditions, and Media 
A. castellanii ATCC30010 was cultured in PYG 712 medium (2% proteose-peptone, 0.1% yeast 
extract, 0.1 m glucose, 4 mm MgSO4, 0.4 m CaCl2, 0.1% sodium citrate dihydrate, 0.05 mm 
Fe(NH4)2(SO4)2 × 6 H2O, 2.5 mm NaH2PO4, and 2.5 mm K2HPO4) at 20 °C. Escherichia coli DH5α was 
used to clone recombinant plasmid DNA. Experiments were done with L. pneumophila Paris (CIP 
107629 (25)). As described previously (28), Lp strains were cultured in AYE medium (ACES-buffered 
yeast extract broth: 10 g of ACES, 10 g of yeast extract, 0.4 g of l-cysteine, and 0.25 g of iron 
pyrophosphate in 1 liter (pH 6.8)) (see also supplemental Table S1) or on ACES-buffered charcoal-
yeast extract (BCYE) agar plates at 37 °C. Alternatively, Lp Paris was cultivated in a chemically 







C Labeling Experiments  
1 liter of growth medium (AYE or CDM) was supplemented with 2 g of [U-
13
C6]glucose, 2 g of [1,2-
13
C2]glucose, or 0.3 g of [U-
13
C3]Ser. 500 ml of the supplemented AYE medium was inoculated with 1 
ml of an overnight culture of Lp Paris. For supplemented CDM the inoculum was 4 ml of an overnight 
culture grown in AYE medium. Incubation was carried out at 37 °C and 220 rpm, and the optical 
density at 600 nm (A600) was determined at regular intervals. An A600 of 1.0 was determined as 
exponential growth, whereas an A600 of ∼2.0 correlated with stationary growth. Cultures in AYE 
medium reached exponential growth after 16 h and stationary growth at 29 h. Cultures grown in CDM 
became stationary at 40 h. Before harvesting, a culture aliquot was plated on LB agar plates to rule 
out the possibility of contamination. The bacteria were killed with sodium azide at a final concentration 
of 10 mm and pelleted at 5500 × g and 4 °C for 15 min. The pellet was washed twice with 200 ml of 
water and then once with 2 ml of water. The supernatant was discarded, and the bacterial pellet was 
autoclaved at 120 °C for 20 min.  
 
Strain Construction 
The lpp0483 mutant strain of Lp Paris (Δzwf) was constructed as described previously (28, 38). In 
brief, the gene lpp0483 (zwf) was inactivated by insertion of a kanamycin resistance (kan
R
) cassette 
into the chromosomal gene. The chromosomal region containing the lpp0483 gene was PCR-amplified 
with the primers lpp0483_for and lpp0483_rev, and the product (2639 bp) was cloned into the pGEM-T 
Easy vector (Promega). On this template, an inverse PCR was performed using the primers 
lpp0483_inv_for and lpp0483_inv_BamHI_rev, with the reverse primer bearing a BamHI restriction 
site. These primers amplified 4912 bp corresponding to the pGEM backbone and the flanking regions 
of lpp0483. The resulting PCR product was BamHI-digested and ligated to the kan
R
 cassette (1210 bp 
amplified via PCR from the plasmid pGEM-Kan
R
 subcloned into a pGEM-T Easy vector) using primers 
containing BamHI restriction sites at the ends (Kan_BamHI_for and Kan_BamHI_rev). All primers are 
listed in Table 1. For chromosomal recombination, the construct (i.e. PCR fragment containing the 
kan
R
 cassette with flanking regions of the gene of interest, ∼900 bp upstream and ∼250 bp 
downstream) was introduced into the Lp Paris strain by transformation. Three independent Δzwf 
mutant strains were generated, and two of them were used for intracellular replication assays.  
 
Intracellular Multiplication in A. castellanii 
For in vivo growth of Lp Paris and its derivatives in A. castellanii, we followed a protocol described 
previously (28). In brief, 3-day-old cultures of A. castellanii were washed in AC buffer (PYG 712 
medium without proteose-peptone, glucose, and yeast extract) and adjusted to 5 × 10
5
 cells. 
Stationary phase Legionella bacteria grown on BCYE agar were diluted in water and mixed with A. 
castellanii at a multiplicity of infection of 0.01. After invasion for 1 h at 37 °C, the A. castellanii layer 
was washed twice, defining the start point of the time course experiment. The number of colony 
forming units (CFU) of legionellae was determined by plating on BCYE agar. Each infection was 
carried out in duplicates and was done at least three times.  
 
Intracelluar Multiplication/Survival in A. castellanii 
The intracellular multiplication was carried out as described above but without the washing step. After 
3 days, A. castellanii cells were resuspended, 100-μl aliquots were lysed, and serial dilutions were 
spread on BCYE agar to determine the number of CFU. To study the replication rates in repeating 
rounds of infection, the remaining solution was incubated at 37 °C for a further 3 days and diluted 
(1:1000). The number of CFU was determined by plating the remaining solution on BCYE agar. 1 ml of 
the remaining dilution was used to reinfect fresh amoeba cultures as described previously. Four 
rounds of infection were performed in total, and each infection was carried out in duplicates and done 





Intracelluar Multiplication/Survival Assay in “Competition” 
The infection procedure was similar to the assay described above, but equal amounts of bacteria of 
the wild type and the Δzwf mutant strain (kanamycin resistant) were used together to co-infect the A. 
castellanii cells. After 3 days, A. castellanii cells were resuspended, 100-μl aliquots were lysed, and 
serial dilutions were spread on BCYE agar with and without kanamycin to determine the number of 
CFU. The remaining infection solution was incubated at 37 °C for a further 3 days and diluted 
(1:1000). The resulting solution was used to determine the number of CFU on BCYE with and without 
kanamycin and to reinfect fresh amoebae. Four rounds of infection were performed in total. To 
determine the number of wild type bacteria, the CFU on BCYE-kanamycin agar was subtracted from 
the CFU on BCYE plates without kanamycin. In the survival assay, the mixture of the first infection 
was incubated for a further 19 days. To follow the Δzwf and WT strain recovery capabilities, each 
sample was plated (100 μl) on BCYE and/or BCYE-kanamycin plates. Each infection was carried out 
in duplicates and was done at least three times.  
 
RT-PCR 
Total RNA was extracted from bacteria grown in AYE medium to the appropriate growth phase, 
incubated with Dnase I, and then repurified. RT-PCR reactions were performed with a OneStep RT-
PCR kit (Qiagen) using gene-specific primers. The RT reaction was carried out at 50 °C for 30 min 
with 0.5 μg of total RNA. PCR amplification was performed with each primer at 0.6 μm and each dNTP 
at 400 μm in 1× OneStep RT-PCR buffer containing 12.5 mm MgCl2 and 2 μl of OneStep RT-PCR 
enzyme mix. The total volume was 50 μl. The cycling conditions were 94 °C for 1 min, 53–55 °C for 1 
min, and 72 °C for 1 min for 25 to 35 cycles with a Thermocycler. The following gene-specific primer 
pairs were used: accC-For and accC-Rev; edd-For and edd-Rev; fadD-For and fadD-Rev; fumC-For 
and fumC-Rev; pfp-For and pfp-Rev; pykA-For and pykA-Rev; ppsA-For and ppsA-Rev; rpiA-For and 
rpiA-Rev; and sucA-For and sucA-Rev. All primers used for RT-PCR are listed in Table 1.  
 
 
Primers used in this study 
Protein Hydrolysis and Amino Acid Derivatization 
Bacterial cell mass was suspended in 6 m hydrochloric acid and heated at 105 °C for 24 h under an 
inert atmosphere. The hydrolysate was placed on a cation exchange column of Dowex 50W×8 (H
+
 
form, 200–400 mesh, 5 × 10 mm) that was washed with water and developed with 2 m ammonium 
hydroxide. An aliquot of the eluate was dried under a stream of nitrogen, and the residue was 
dissolved in 50 μl of water-free acetonitrile. A mixture of 50 μl of N-(tert-butyldimethylsilyl)-N-methyl-
trifluoroacetamide containing 1% tert-butyldimethylsilylchloride (Sigma) was added. The mixture was 
kept at 70 °C for 30 min. The resulting N-(tert-butyldimethylsilyl) (TBDMS)-amino acids were then 
analyzed by GC/MS.  
 
 
Dichloromethane Extraction and Isolation of Amino Acids 
The dried sample was heated under reflux with 10 ml of dichloromethane/100 mg of sample for 1 h. 
After filtration the filtrate was evaporated.  
The filtered residue was dried and hydrolyzed with 6 m hydrochloric acid containing 0.5 mm 
thioglycolic acid. The mixture was boiled for 24 h under an inert atmosphere and then filtered. The 
solution was concentrated to a small volume under reduced pressure and lyophilized. The residue was 
dissolved in 8 ml of water. The solution was placed on top of a column of Dowex 50W×8 (H
+
 form, 3 × 
33 cm). The column was washed with 300 ml of water and then was developed with a linear gradient 
of 0–3 m hydrochloric acid (total volume, 2 liters). Fractions were collected, combined, evaporated to a 
small volume under reduced pressure, and lyophilized (36).  
  
Mass Spectrometry 
GC/MS analysis was performed on a GC-17A gas chromatograph and/or GC 2010 (Shimadzu, 
Duisburg, Germany) equipped with a fused silica capillary column (Equity TM-5; 30 m × 0.25 mm, 0.25 
μm film thickness; SUPELCO, Bellefonte, PA) and a QP-5000 and/or GC-QP2010 plus mass selective 
detector (Shimadzu) working with electron impact ionization at 70 eV. An aliquot (1 μl) of a solution 
containing TBDMS amino acids was injected in a 1:10 split mode at an interface temperature of 260 
°C and a helium inlet pressure of 70 kilopascals. The column was developed at 150 °C for 3 min and 
then with a temperature gradient of 10 °C/min to a final temperature of 280 °C that was held for 3 min. 
Data were collected using Class 5000 and/or GCMS Solution software (Shimadzu). Selected ion 
monitoring data were acquired using a 0.3-s sampling rate. Samples were analyzed at least three 
times. The theoretical isotope ratio and numerical deconvolution of the data were computed according 
to standard procedures: (i) determination of the “TBDMS derivate” spectrum of TBDMS-amino acid, (ii) 
determination of the mass isotopomer distribution of the labeled amino acid, and (iii) correction for 
incorporation of 
13






C NMR spectra were recorded at 25 °C using a DRX-500 spectrometer (Bruker Instruments, 
Karlsruhe, Germany) at transmitter frequencies of 500.1 and 125.6 MHz, respectively. Extracts with 
dichloromethane were dissolved in CDCl3, and amino acids were measured in 0.1 m DCl. 
13
C 
enrichments were determined by quantitative NMR spectroscopy. For this purpose, 
13
C NMR spectra 
of the biolabeled specimens and of samples with natural 
13
C abundance (i.e. with 1.1% 
13
C 
abundance) were measured under the same experimental conditions. The ratios of the signal integrals 
of the labeled compounds and of the compounds at natural abundance were then calculated for each 
respective carbon atom. Absolute 
13
C abundances for certain carbon atoms (i.e. for carbon atoms with 
at least one attached hydrogen atom displaying a 
1
H NMR signal in an uncrowded region of the 
spectrum) were determined from the 
13
C coupling satellites in the 
1
H NMR spectra. The relative 
13
C 
abundances determined for all other positions were then referenced to this value, thus affording 
absolute 
13
C abundances for every single carbon atom. 
13
C-coupled satellites were integrated 
separately. The relative fractions of each respective satellite pair (corresponding to a given coupling 
pattern) in the total signal integral of a given carbon atom were calculated. These values were then 
referenced to the global 
13
C abundance affording concentrations of multiple 
13
C-labeled isotopologue 





Growth of Lp in Culture under Standardized Conditions 
Cultures of Lp can be grown in various media although not in a medium that comprises only one 
possible carbon source. Typically, so-called AYE medium is used, which consists of yeast extract and 
ACES buffer and high amounts of iron ions and cysteine. However, it is also possible to use a 
chemically defined medium consisting of ACES, 16 amino acids (not included are Ala, Gly, Asn, and 
Gln), ammonium chloride, and some inorganic salts (again including high amounts of iron ions; for 
details, see supplemental Table S1). To estimate the impact of the culture medium on the growth and 
metabolism of Lp, we cultivated the bacterium for 2 days at 37 °C in duplicates in 500 ml of AYE 
medium or CDM, each supplemented with 11 mm glucose. At timed intervals, the optical density at 
600 nm (A600) and the CFU were determined. Lp Paris had a generation time of 2.7 h in AYE medium 
and 4.4 h in CDM, and the final cell densities (optical density) were ∼2.1 and 1.4, respectively (data 
not shown).  
 
Serine Serves as a Major Carbon Substrate for Lp 
In earlier studies, Ser was shown to support the growth of Lp (10, 14, 15), and high activity levels of 
Ser dehydratase converting Ser into pyruvate were detected in cell-free extracts of the bacterium (20). 
  
To analyze the metabolic fate of Ser in more detail, we added 3 mm [U-
13
C3]Ser to the AYE medium 
(for details, see “Experimental Procedures”) and grew Lp for 29 h until the cells entered stationary 
phase (A = 2.1 at 600 nm). PHB and amino acids were extracted from the cells and analyzed by 
GC/MS and/or quantitative NMR spectrometry (for details, see “Experimental Procedures”).  
 
NMR Analysis of the Dichloromethane Extract 
The 
13
C NMR spectrum of the dichloromethane extract showed four intense signals due to PHB 
(supplemental Fig. S1A; Table 2). Notably, the spectrum did not display signals of lipids or fatty acids 




C couplings at high 
intensities. The quantitative signal analysis (Table 3) showed that ∼3 mol % of PHB was multiply 
13
C-
labeled and therefore derived from the supplied [U-
13
C3]Ser or a multiply 
13
C-labeled downstream 
product. The coupling pattern (i.e. the size of the coupling constants for each carbon signal; Table 2) 




C2]PHB were the predominant multiply 
13
C-labeled species. 
The isotopologue pattern can be explained by the well known mechanisms of PHB formation (7, 8) 
from [1,2-
13
C2]acetyl-CoA and unlabeled acetyl-CoA (from the degradation of unlabeled components 









C2]hydroxybutyryl-CoA, respectively, which was then 
condensed to PHB with the detected isotopologue composition. The minor U-
13
C4-isotopologue in PHB 




GC/MS Analysis of Protein-derived Amino Acids 
GC/MS analysis showed that 25% of the protein-derived Ser carried 
13
C label (Fig. 2, gray bar; see 
numerical values in supplemental Table S3). Not unexpectedly, this finding documented that 
exogenous Ser was efficiently incorporated into Lp and was used for protein biosynthesis. The high 
13
C enrichment values of other amino acids (3–12%; Ala > Glu > Gly = Asp; Fig. 2, gray bars) as well 
as the 
13
C enrichment in PHB (3%) indicated that Ser was also shuffled into the central carbon 
metabolism of Lp where it was converted into pyruvate/Ala, oxaloacetate/Asp, and α-
ketoglutarate/Glu, as well as into acetyl-CoA serving as a precursor of PHB. However, the 
13
C 
enrichments of those metabolites were significantly lower (3–12%) than that of Ser (25%) suggesting 
(i) that higher fractions of Ala, Glu, Gly, and Asp were incorporated from the medium (i.e. in unlabeled 
form) as compared with Ser; and/or (ii) as expected, that Ser was not the unique carbon source for Lp 
under the experimental conditions and that, next to 
13
C-labeled Ser, unlabeled carbon substrates were 
shuffled into the biosynthetic pathways of Ala, Glu, Gly, and Asp. The lack of label in Ile, Leu, Val, and 
Tyr showed that these amino acids were derived from unlabeled amino acids present in the medium 
and/or were not synthesized de novo. Albeit with high standard deviations, a slight 
13
C enrichment was 
detected in Pro, Thr, and Tyr. It remains open as to whether these amino acid were made de novo 
under the experimental conditions (16, 18).  
The mass data also revealed the abundances of 
13
C-labeled isotopologues comprising a given 
number of 
13
C atoms (Fig. 2, patterned columns; see numerical values in supplemental Table S4). Ser 
and Ala were characterized by 
13
C3-isotopologues, whereas Asp and Glu were more complex mixtures 
of species comprising one, two, and three 
13






NMR Analysis of Protein-derived Amino Acids 
To localize the label distribution at higher resolution, purified amino acids were also analyzed by 
quantitative NMR spectroscopy (36). Many of the 
13
C NMR signals were multiplets caused by 
couplings between adjacent 
13
C atoms in a given molecule. As examples, 
13
C NMR signals of the C-3 
of Asp and the C-2 of Ala are shown in supplemental Fig. S2. From the signal intensities of the 
satellites, the molar abundances of the underlying isotopologues were calculated and referenced to 
the values obtained by mass spectrometry. The coupling patterns of all labeled amino acids are shown 
graphically in Fig. 3 with bars connecting 
13
C-labeled atoms in multiple 
13
C-labeled isotopologues (see 
also supplemental Table S5).  
  
The labeling patterns of Ser and Ala were characterized by a high abundance of the triple 
13
C-labeled 
isotopologues and minor amounts of 1,2-
13
C2-isotopologues. The triple 
13
C-labeled isotopologues of 
Ser and Ala can be explained easily by the direct incorporation of exogenous [U-
13
C3]Ser into the 




C3]pyruvate. It appears safe to assume that the later compound is derived from [U-
13
C3]Ser by Ser 
dehydratase (Fig. 3, red arrow). The detection of the 1,2-
13
C2-isotopologues lends support for the 
existence of Ser recycling via reactions of gluconeogenesis (Fig. 3). More specifically, the formation of 
phosphoenolpyruvate from [1,2-
13





C2]phosphoglycerate serving as the precursor of [1,2-
13
C2]Ser, which was then further converted into [1,2-
13
C2]pyruvate/Ala by Ser dehydratase.  
The labeling profile of PHB can be taken as a reference for the labeling pattern of its precursor, acetyl-
CoA. On this basis, the presence of [1,2-
13




C2]pyruvate by pyruvate dehydrogenase. This isotopologue was then used for PHB synthesis but 
could also be shuffled into the citrate cycle, affording specific isotopologue profiles in α-ketoglutarate 
and oxaloacetate, which serve as precursors for Glu and Asp, respectively (Fig. 3). Because of a Si-
specific citrate synthase, label from [1,2-
13
C2]acetyl-CoA (Fig. 3, red bar) was transferred to positions 4 






C2]fumarate (Fig. 3, red bars). Because of 






C2] fumarate. (Fig. 3, green bars). The same isotopologue mixture resulted in 
oxaloacetate and its amination product, aspartate (Fig. 3, green bars and M+2 values from the mass 
spectrum). The presence of triple 
13
C-labeled isotopologues in Asp (Fig. 3, blue bars and M+3 values) 
also reflected the formation of oxaloacetate by carboxylation of [U-
13
C3]pyruvate (Fig. 3, blue arrow). 




C3]oxaloacetate, which was then 
converted into [1,2,3-
13
C3]Asp. The fact that [2,3,4-
13
C3]oxaloacetate/Asp also was observed at similar 
abundances as found for the 1,2,3-
13
C3-isotopologue can be explained by rapid equilibrium between 
oxaloacetate/malate/fumarate due to reversible malate dehydrogenase, malate synthase, and possibly 
also succinate dehydrogenase. Because of the symmetry of fumarate and succinate, the triple label 
was then randomized, affording the observed symmetric isotopologue distribution in oxaloacetate/Asp.  
Labeled oxaloacetate also served as an acceptor of unlabeled acetyl-CoA. As shown in Fig. 3, label 
from [3,4-
13





C1]Glu. Label from position 1 of oxaloacetate was lost as 
13
CO2 









C3-labeled species in α-ketoglutarate/Glu, respectively. Notably, all of these isotopologues 
were detected in glutamate, although [1,2,3-
13
C3]Glu could be identified only by mass spectrometry (as 
M+3 species).  
 
Lp Is Able to Use Glucose as a Carbon Source 
To obtain information about a potential usage of glucose, Lp was grown in AYE medium or CDM 
supplemented with 11 mm [U-
13
C6]glucose and harvested at stationary phase. A sample work-up and 
analysis were done as described above. Fig. 4 indicates that the same set of amino acids labeled from 
[
13
C]Ser also acquired significant 
13
C label (>1% 
13
C enrichment; Ala > Glu > Asp > Pro > Ser) from 
[U-
13
C6]glucose supplemented either to the AYE medium or to CDM. The percentage of enrichment 
values of amino acids was remarkably similar, pointing to glucose metabolism irrespective of the 
culture medium used. In contrast to the small differences in the 
13
C enrichments of amino acids, we 
noticed a rather large difference in the 
13
C incorporation of [U-
13
C6]glucose into PHB. More specifically, 
13
C enrichment of PHB isolated from cells grown in AYE medium was ∼3-fold higher than the 
corresponding value in the experiments using CDM. The labeling patterns from the experiment with 
AYE medium are discussed in detail below.  
 
Elevated Rate of Glucose Incorporation into PHB 
The 
13
C NMR signals of PHB detected in the dichloromethane extract of the labeled cells 
(supplemental Fig. S1B) displayed the same coupling pattern as observed previously for PHB labeled 
from [U-
13
C3]Ser. However, the intensities of the coupling satellites relative to the central signals were 
  
higher in the experiment with [U-
13





C2]PHB were again the dominant species, each with abundances of 
approximately 5%. As described above in detail, this isotopologue mixture can be explained by PHB 
biosynthesis from a mixture of 1,2-
13
C2-labeled and unlabeled acetyl-CoA. The minor [U-
13
C4]PHB 
species was again assembled from two labeled molecules of acetyl-CoA. In summary, these data 
demonstrated that [U-
13




C6]glucose, indicating that 
Ser and glucose catabolism merge at a certain stage of the intermediary metabolism (i.e. prior to 
acetyl-CoA formation). During growth in AYE medium, glucose appeared to be used preferably as a 
PHB precursor. Under these conditions more than 6 mol % of PHB was derived from exogenous 
[
13





C incorporation into the bacterial amino acids as determined by GC/MS and NMR was 0.5–5% 
in the following order: Ala > Asp > Glu > Ser > Gly (Figs. 4 and 5). The same set of amino acids was 
also found to be labeled from [U-
13
C3]Ser, although at higher rates (3–12%). Generally, the relatively 
low incorporation rates of glucose into amino acids suggested that glucose did not serve as a major 
carbon source during the overall growth period of the experiment. Notably, the incorporation of 
glucose into pyruvate/alanine (4.9%) was considerably lower than the rate into PHB (6.3%). This was 
in sharp contrast to the values of the experiment with [U-
13
C3]Ser where the incorporation rate into 
PHB was lower (3.2%) than the respective value into pyruvate/alanine (12.2%). The discrepancy 
between the 
13
C enrichments in pyruvate (serving as precursor for Ala) and acetyl-CoA (serving as 
precursor for PHB) immediately showed that these intermediates were not in isotopic equilibrium.  
Ile, Leu, Phe, Tyr, His, Pro, and Val were also found to be unlabeled from [U-
13
C6]glucose. This 
confirms that Lp is auxotrophic for these amino acids as suggested. Surprisingly, some label appeared 
to be transferred from glucose to Ser, although exogenous Ser had been shown to be incorporated 
efficiently into proteins in the previous experiment. Moreover, a weak 
13
C enrichment of Thr also could 
not be excluded on the basis of our experimental data.  
The isotopologue distribution in each of the labeled amino acids was then determined by mass 
spectrometry and NMR spectroscopy as described before. Ala was characterized by the U-
13
C3-
isotopologue. This isotopologue can be explained by glucose utilization via glycolysis, the PP 
pathway, and/or the ED pathway (Fig. 6). At lower abundances, Ser was also present as a U-
13
C3-
isotopologue, suggesting that 3-phosphoglycerate acquired at least some 
13
C label by glycolysis. [1,2-
13
C2]Ala was observed as a minor isotopologue, suggesting that a small fraction of 
phosphoenolpyruvate/ pyruvate was made from [1,2-
13
C2]oxaloacetate by decarboxylation (Fig. 6, 
green arrow). The labeling patterns in Asp and Glu supported carbon flux via the complete citrate 
cycle as already shown by the respective labeling profiles from [U-
13
C3]Ser. Thus, formation of 
oxaloacetate from pyruvate was again detected on the basis of 
13




C2-isotopologues in Glu.  
 
Glucose Is Catabolized by the Entner-Doudoroff Pathway in Lp 
To determine the glucose utilization pathway, we performed a labeling experiment with Lp Paris (Lp) in 




C enrichments and patterns in amino 
acids and PHB (Fig. 4, lane e) followed the same rules as described above. As shown in supplemental 
Fig. S3, label from [1,2-
13
C2]glucose was transferred at high rates to [1,2-
13
C2]Ala via the ED pathway 
but not to a 2,3-
13
C2-labeled specimen representing a hypothetical product via glycolysis. Moreover, 
the apparent lack of label in Ser was also in line with the ED pathway, because glycolysis should have 
generated [2,3-
13
C2]Ser. The PP pathway was also excluded as a major pathway for utilizing glucose 
because no or only single labeled pyruvate/Ala (
13
C at C-3) should have occurred when [1,2-
13
C2]glucose was catabolized by this route. The low, single 
13
C enrichment at C-1 of pyruvate/Ala 
rather reflected minor carbon flow from [
13
C]oxaloacetate as already outlined above (supplemental Fig. 











C1]PHB specimens. The labeling patterns of 
Asp and Glu were also in full accordance with the carbon fluxes described above for the earlier 
  
experiments. Thus, our results identified the ED pathway as the predominant route of glucose 
catabolism in Lp.  
 
Construction, Properties, and Isotopologue Profiling of a Δzwf Mutant Strain 
To further investigate the role of the ED pathway for glucose utilization in Lp, we constructed a mutant 
of Lp Paris in which we deleted the gene lpp0483 (Δzwf), which codes a key enzyme of the ED 
pathway necessary for the conversion of glucose 6-phosphate into 6-phosphogluconolactone (Fig. 7). 
To investigate whether the putative zwf operon (lpp0483–0488) is expressed as a polycistronic mRNA, 
we conducted RT-PCR experiments. Indeed, the genes lpp0483 to lpp0487 were co-transcribed; 
however, gene lpp0488 encoding a putative glucose transporter was transcribed separately (Fig. 7). 
To exclude possible downstream effects of the deletion of zwf, we analyzed the transcription of the 
downstream genes, which confirmed that there were no polar effects due to the mutation (data not 
shown).  





described above for the wild type strain. The Δzwf mutant strain showed strongly reduced 
incorporation rates (by an approximate factor of 10) into PHB and amino acids (Fig. 4, lanes f and g). 
On the basis of this drastic modulation, we concluded (i) that the protein encoded by lpp0483 was 
functionally involved in glucose metabolism and most probably catalyzed the presumed conversion of 
glucose 6-phosphate into 6-phosphogluconolactone and (ii) that the ED pathway was the predominant 
route for glucose catabolism. Nevertheless, the occurrence of 
13
C label in Ala and PHB (clearly 
indicated by the mass spectrum of alanine and the coupling satellites in the NMR spectrum of alanine 
and PHB; cf. supplemental Fig. S1 and Table 3) showed that [U-
13
C6]glucose was still converted 
(albeit at very low rates) into pyruvate and acetyl-CoA serving as precursors for alanine and PHB, 
respectively. It can be hypothesized that the minor flux of glucose into pyruvate and acetyl-CoA 
existed via glycolysis in the mutant. Notably, the enzymes required for glycolytic conversion of glucose 
are present in the genome of Lp.  
 
Hints for a Functional Role of Carbohydrate Utilization by Lp 
To better understand the role of glucose metabolism in the life cycle of Lp, we ran infections of A. 
castellanii. The deletion of zwf in Lp did not significantly affect replication within the host (Fig. 8A). 
However, this was different when replication during successive rounds of infection was analyzed. After 
a first infection, which lasted 3 days, the mixture (comprising amoeba lysate and Lp WT or Δzwf 
mutant strain) was kept for 3 additional days. Then, we ran another infection using 1 ml of a 1:1000 
dilution of the previous mixture in fresh infection buffer with fresh amoebae. To follow infection 
kinetics, each sample was plated on BCYE and/or BCYE kanamycin plates. Although there was only a 
minor difference during the second and third round of infection of amoebae (Fig. 8B), we noted that 
the viability of the Δzwf mutant strain dropped during the lag period. We then verified this observation 
by an experiment with a lag period of 20 days between the first and second rounds of co-infection and 
by evaluating the recovery percentage (ratios of Δzwf/Δzwf + WT) of both the mutant and the wild type 
strain (Fig. 8C). Then, we performed competition experiments with successive rounds of infection 
using the Δzwf mutant strain and the WT strain. Again, the mutant strain showed less fitness, and the 
observed effect accumulated with each additional round of infection until the mutant strain was 
outcompeted by the WT strain (Fig. 8D). Altogether, these results indicate an important role of the ED 






Lp survives within amoebae and macrophages because of its ability to establish a replication vacuole 
that is derived from the endoplasmic reticulum. Within this vacuole, Lp differentiates into the replicative 
form and multiplies. It was proposed that when nutrients become limiting, a regulatory cascade 
triggers the differentiation to a motile spore-like form. After the bacteria are released from the host 
cells, these forms of Lp are well prepared to persist for long periods in the environment. It is known 
that Legionella exhibits a strictly respiratory form of metabolism and does not grow anaerobically (18). 
It is also current knowledge that Lp uses amino acids as primary energy and carbon sources (4, 10,–
,12, 14) and that metabolic genes are expressed mainly in the exponential growth phase during in vivo 
growth within A. castellanii (28).  
In this study, the metabolism of Lp was analyzed for the first time by comprehensive isotopologue 
profiling under culture conditions. Metabolic fluxes were estimated on the basis of the observed 
labeling profiles in amino acids and PHB. It had been reported previously that Ser is actively 
metabolized by legionellae and that Ser is necessary for the growth of Lp (10, 12, 14,–,16, 18, 19, 27). 
In the genome of strain Paris genes encoding for ∼12 ABC transporters and amino acid permeases, 
e.g. a putative Ser transport protein (Lpp2269) and the putative amino acid transporters Lpp0026 and 
Lpp0357 are predicted. Indeed, using [U-
13
C3]Ser as a supplement to AYE medium at a concentration 
of 3 mm, label was transferred to protein-derived [
13
C3]Ser at ∼25%. Assuming that yeast extract 
present in AYE medium contributes unlabeled Ser at a similar concentration as the added 
13
C-labeled 
Ser (see also supplemental Table S1), the incorporation of exogenous Ser into protein-derived Ser 
can be estimated as 50%. This high value supports the view that amino acid transporters, accepting 
Ser as a substrate, are active in Lp. Albeit at lower levels of 
13
C enrichment (0–13%), label from [U-
13
C3]Ser was also distributed to other amino acids (Ala, Glu, Gly, and Asp) as well as to PHB. This 
lends evidence that Ser is catabolized to pyruvate by Ser dehydratase, known to be active in cell 
extracts of Lp (20). The enrichment values and isotopologue profiles of the storage compound, PHB, 
and amino acids derived from intermediates of the citrate cycle (i.e. Asp and Glu) also demonstrate 
that a carbon flux exists from pyruvate to acetyl-CoA serving as a precursor of PHB and a substrate of 
a complete citrate cycle with Si specificity of citrate synthase. Our data did not show any evidence for 
a functional glyoxylate bypass, corroborating data from genome sequence analysis (18, 25, 26).  
The labeling profiles reflected only minor flux from pyruvate to oxaloacetate as well as from 
oxaloacetate to phosphoenolpyruvate/pyruvate by reactions of gluconeogenesis (including formation 
of [
13
C2]Ser indicating that Ser can be made de novo). This is surprising because it was believed that 
the EMP pathway is used in the direction of gluconeogenesis and that Ser or pyruvate is required to 
maintain a pool of oxaloacetate (high activity of pyruvate carboxylase (20)). In addition, our results 
could not corroborate minor flux from pyruvate to acetyl-CoA, as suggested earlier on the basis of low 
activity for pyruvate dehydrogenase in cell lysates of Lp (20). However, at this time it is not possible to 
reach a conclusion on the importance of gluconeogenesis for Lp. Experiments are under way to 
investigate this question further.  
The fact that many amino acids (Leu, Ile, Val, Phe, Tyr, Met, Arg, and His) were unlabeled corroborate 
that Lp is auxotrophic for many amino acids, as suggested by genome analysis (16, 18), and that 
amino acids (including Ser) can act as major carbon substrates for Lp. On the other hand, the 
detection of diluted label from exogenous [U-
13
C3]Ser in metabolites derived from downstream central 
intermediates (i.e. acetyl-CoA, oxaloacetate, and α-ketoglutarate) lends support for the use of 
additional non-amino acid carbon substrates.  




C2]glucose as a supplement to AYE medium or CDM. In both experimental settings, glucose was 
incorporated into amino acids and PHB, affording 
13
C enrichments up to 10% in pyruvate/Ala. Again, 
minor amounts of Ser were synthesized de novo in this experiment. Generally, the transfer of label 
from glucose to central metabolic intermediates providing precursors of the labeled amino acid is 
surprising, because it is believed that glucose or carbohydrates are not utilized by Lp (12, 15, 18, 20). 
Although the glycolytic pathway appeared to be complete (as suggested from the sequenced 
genomes), enzymatic assays indicated very low, if any, metabolic flux through this route (14, 16, 20). 
In addition, we confirmed that Lp does not exhibit a functional PP pathway, corroborated by the lack of 
orthologues of 6-phosphogluconate dehydrogenase and transaldolase within the recently sequenced 
Lp genomes. The ED pathway was also not thought to be active (16, 18). However, in our 
  
experiments, the labeling profiles of PHB and amino acids demonstrated carbon flux from glucose to 
pyruvate via the ED pathway and not via the EMP and/or the PP pathway. As further strong evidence, 
the Δzwf mutant of Lp Paris, impaired in the key reaction of the ED pathway, was strongly reduced in 
its glucose utilization. However, the deletion of the zwf gene would also affect the catabolism of 
glucose via the PP pathway; but this seems to be a negligible concern, because our results (WT 
strain) demonstrated that the PP pathway was not used for glucose catabolism by Lp.  
Further analysis of the putative zwf operon demonstrated that the genes lpp0483 to lpp0487 are 
transcribed as one mRNA unit. The putative glucose transport protein encoding gene lpp0488 is 
transcribed separately as a monocistronic mRNA. It is also noteworthy that the glucokinase (glk, 
lpp0486) is located within the zwf operon encoding for genes of the ED pathway. The products of 
glucose degradation by the encoded enzymes of the zwf operon would be glyceraldehyde 3-
phosphate and pyruvate, which could then enter into the lower part of glycolysis and the citrate cycle, 
respectively (see Fig. 7).  
Further analysis of the Δzwf mutant strain demonstrated that the mutant strain was outcompeted by 
the wild type strain in a combined replication/survival assay with successive rounds of infection (Fig. 
8D). In the first round of infection, the Δzwf mutant strain replicated as well as the wild type strain; 
however, during repeated infection cycles, the fitness of the Δzwf mutant strain was reduced in the 
presence of the wild type strain. Thus, the activity of glucose-6-phosphate dehydrogenase (ED 
pathway) and of glucose catabolism in general is important for full fitness of Lp.  
In this context, it is important to note that Lp is also able to degrade cellulose (29), and we have 
identified a glucoamylase in Lp Paris the activity of which is responsible for starch and glycogen 
degradation of this strain.
6
 Moreover, it has been shown that a mutation in the chitinase gene (chiA) 
has a negative effect on the virulence of the mutant strain as compared with the isogenic wild type 
strain (40). Preliminary labeling experiments of A. castellanii, the host organism, were successful. 
Thus we now have an excellent basis for in vivo infection experiments using Lp and “prelabeled” A. 
castellanii cells to analyze the intracellular metabolism of the human pathogen Lp. This will provide 
further information for better understanding the mechanisms of intracellular pathogens and how Lp 
gets access to essential nutrients during intracellular parasitism of amoebae.  
In summary, we were able to demonstrate that (i) Ser is used efficiently as a carbon source but is also 
synthesized de novo by Legionella, although Ser is absolutely required for in vitro and in vivo growth 
of Lp; (ii) glucose is metabolized mainly via the ED pathway, which is active during in vitro growth, and 
not via the EMP or PP pathway; (iii) carbon from glucose is incorporated preferably into the storage 
compound PHB; (iv) the citrate cycle is complete and active; (v) Lp is not able to synthesize Ile, Leu, 
Val, Phe, Met, Arg, and Tyr; and (vi) glucose metabolism via the ED pathway is necessary for full 
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Table 2 NMR data of 
13






 Coupling partners are indicated in parentheses. 
  







is indicated by bars connecting 
13
C-labeled atoms. The patterns of acetoacetyl-CoA and downstream 
products are overlays of isotopologues comprising two 
13











C excess (gray columns; in mol % (right scale)) and isotopologue composition (patterned 
columns) of amino acids from the experiment with [U-
13
C3]Ser. The values represent means from three 
technical replicates, and the error bars indicate S.D. The patterned boxes indicate the relative 
contribution (% (left scale)) of 
13







Figure 3 Metabolic model for Ser utilization by Lp Paris grown in culture. The scheme shows labeling 
patterns due to the incorporation of exogenous [U-
13
C3]Ser. Labeling patterns were detected in 
protein-derived amino acids and PHB (shown in boxes). Multiple 
13
C-labeled isotopologues 
determined by NMR spectroscopy are indicated as bars connecting 
13
C-labeled atoms in a given 
molecule. The numbers indicate the respective molar abundances. The molar abundances of 
isotopomer groups comprising one, two, or three 
13
C-labeled atoms, as determined by mass 
spectrometry (M+1, M+2, and M+3, respectively), are also listed in the boxes. PEP, 




Figure 4 Overall 
13
C excess (mol %) of labeled isotopologues in amino acids derived from protein after 
feeding of L. pneumophila Paris wild type and Δzwf mutant with 11 mm [U-
13
C6]glucose and 11 mm 
[1,2-
13
C2]glucose in different media. The color map indicates 
13
C excess in quasi-logarithmic form to 
show even relatively small 
13
C excess values. Each sample (different labeling experiments) was 
measured three times; the color for each amino acid correlates with the mean value of the three 
measurements. Asterisks indicate S.D. > 35%. PHB could not be measured in the experiment with 
[1,2-
13







C excess (gray columns; in mol % (right scale)) and isotopologue composition (patterned 
columns) of amino acids from experiments 1 and 2 with L. pneumophila wild type cultivated in AYE 
medium containing 11 mm [U-
13
C6]glucose. The values represent means from three measurements, 
and error bars indicate S.D. The patterned boxes indicate the relative contribution (% (left scale)) of 
13




Figure 6.  Metabolic model for glucose utilization in Lp Paris grown in AYE medium supplemented 
with [U-
13
C6]glucose. Labeling patterns were detected in protein-derived amino acids and PHB (shown 
in boxes). Multiple 
13
C-labeled isotopologues determined by NMR spectroscopy are indicated as bars 
connecting 
13
C-labeled atoms in a given molecule. The numbers indicate the respective molar 
abundances. The molar abundances of isotopomer groups comprising one, two, or three 
13
C-labeled 
atoms as determined by mass spectrometry (M+1, M+2, and M+3, respectively) are also listed for 
comparison. GAP, glyceraldehyde-3-phosphate dehydrogenase; 6-P-Glcn, 6-phosphogluconate; Pyr, 
pyruvate; OAA, oxaloacetate; α-KG, α-ketoglutarate.  
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e
c
ti
v
e
ly
. 
G
lk
, 
g
lu
c
o
k
in
a
s
e
; 
P
g
i,
 p
h
o
s
p
h
o
g
lu
c
o
s
e
 i
s
o
m
e
ra
s
e
; 
P
fk
, 
p
h
o
s
p
h
o
fr
u
c
to
k
in
a
s
e
; 
F
b
a
, 
fr
u
c
to
s
e
-b
is
p
h
o
s
p
h
a
te
 a
ld
o
la
s
e
; 
T
p
iA
, 
tr
io
s
e
-p
h
o
s
p
h
a
te
 i
s
o
m
e
ra
s
e
; 
G
a
p
, 
g
ly
c
e
ra
ld
e
h
y
d
e
-3
-p
h
o
s
p
h
a
te
 d
e
h
y
d
ro
g
e
n
a
s
e
; 
P
g
k
, 
p
h
o
s
p
h
o
g
ly
c
e
ra
te
 k
in
a
s
e
; 
P
g
m
, 
p
h
o
s
p
h
o
g
ly
c
e
ra
te
 m
u
ta
s
e
; 
E
n
o
, 
e
n
o
la
s
e
; 
P
y
k
A
, 
p
y
ru
v
a
te
 k
in
a
s
e
; 
Z
w
f,
 g
lu
c
o
s
e
-6
-p
h
o
s
p
h
a
te
 d
e
h
y
d
ro
g
e
n
a
s
e
; 
P
g
l,
 p
h
o
s
p
h
o
g
lu
c
o
n
o
la
c
to
n
a
s
e
; 
E
d
d
, 
p
h
o
s
p
h
o
g
lu
c
o
n
a
te
 d
e
h
y
d
ra
ta
s
e
; 
E
d
a
, 
2
-
k
e
to
-3
-d
e
o
x
y
-p
h
o
s
p
h
o
g
lu
c
o
n
a
te
 a
ld
o
la
s
e
; 
G
n
d
, 
6
-p
h
o
s
p
h
o
g
lu
c
o
n
a
te
 d
e
h
y
d
ro
g
e
n
a
s
e
; 
R
p
e
, 
ri
b
u
lo
s
e
 p
h
o
s
p
h
a
te
-3
-e
p
im
e
ra
s
e
; 
R
p
iA
, 
ri
b
o
s
e
-5
-p
h
o
s
p
h
a
te
 
is
o
m
e
ra
s
e
; 
T
k
tA
, 
tr
a
n
s
k
e
to
la
s
e
; 
T
a
l,
 t
ra
n
s
a
ld
o
la
s
e
; 
G
c
d
, 
g
lu
c
o
s
e
 d
e
h
y
d
ro
g
e
n
a
s
e
; 
G
n
t,
 g
lu
c
o
n
a
te
 t
ra
n
s
p
o
rt
e
r 
(m
o
d
if
ie
d
 f
ro
m
 R
e
f.
 1
6
).
 B
, 
s
c
h
e
m
a
ti
c
 
o
v
e
rv
ie
w
 o
f 
th
e
 g
e
n
e
s
 l
p
p
0
4
3
–
lp
p
0
4
8
8
 (
ri
g
h
t)
 a
n
d
 l
p
p
0
1
5
0
–
lp
p
0
1
5
4
 (
le
ft
).
 m
R
N
A
 t
ra
n
s
c
ri
p
ts
 w
e
re
 d
e
te
rm
in
e
d
 v
ia
 R
T
-P
C
R
. 
lp
p
0
4
8
3
, 
z
w
f,
 l
p
p
0
4
8
4
, 
p
g
l;
 
lp
p
0
4
8
5
, 
e
d
d
; 
lp
p
0
4
8
6
, 
g
lk
; 
lp
p
0
4
8
7
, 
e
d
a
; 
lp
p
0
4
8
8
 (
p
u
ta
ti
v
e
 s
u
g
a
r 
tr
a
n
s
p
o
rt
 p
ro
te
in
);
 l
p
p
0
1
5
0
, 
s
d
h
B
 (
s
u
b
s
tr
a
te
 o
f 
th
e
 D
o
t/
Ic
m
 s
y
s
te
m
);
 l
p
p
0
1
5
1
, 
p
y
k
A
; 
lp
p
0
1
5
2
, 
p
g
k
; 
lp
p
0
1
5
3
, 
g
a
p
; 
lp
p
0
1
5
4
, 
tk
tA
. 
  
  
 
 
F
ig
u
re
 8
. 
 A
n
a
ly
s
is
 o
f 
L
. 
p
n
e
u
m
o
p
h
ila
 P
a
ri
s
 (
W
T
) 
a
n
d
 Δ
z
w
f 
m
u
ta
n
t 
s
tr
a
in
 (
z
w
f−
) 
in
 c
o
-c
u
lt
u
re
s
 w
it
h
 A
. 
c
a
s
te
lla
n
ii.
 B
a
c
te
ri
a
 w
e
re
 u
s
e
d
 t
o
 i
n
fe
c
t 
m
o
n
o
la
y
e
rs
 o
f 
A
. 
c
a
s
te
lla
n
ii 
a
t 
a
 m
u
lt
ip
lic
it
y
 o
f 
in
fe
c
ti
o
n
 o
f 
0
.0
1
 w
it
h
 (
A
) 
L
p
 P
a
ri
s
 o
r 
th
e
 Δ
z
w
f 
m
u
ta
n
t 
s
tr
a
in
 f
o
r 
9
6
 h
 (
A
);
 L
p
 P
a
ri
s
 o
r 
Δ
z
w
f 
m
u
ta
n
t 
s
tr
a
in
 f
o
r 
3
 d
a
y
s
, 
re
s
u
s
p
e
n
d
e
d
 a
n
d
 
in
c
u
b
a
te
d
 f
o
r 
a
 f
u
rt
h
e
r 
3
 d
a
y
s
, 
d
ilu
te
d
 t
o
 ∼
1
0
3
 b
a
c
te
ri
a
/m
l,
 a
n
d
 u
s
e
d
 t
o
 i
n
fe
c
t 
fr
e
s
h
 a
m
o
e
b
a
e
 (
B
).
 F
o
u
r 
ro
u
n
d
s
 o
f 
in
fe
c
ti
o
n
 w
e
re
 p
e
rf
o
rm
e
d
. 
C
, 
L
. 
p
n
e
u
m
o
p
h
ila
 Δ
z
w
f 
a
n
d
 W
T
 s
tr
a
in
 s
u
rv
iv
a
l 
o
v
e
r 
a
 2
0
-d
a
y
 p
e
ri
o
d
 a
ft
e
r 
c
o
-i
n
fe
c
ti
o
n
 o
f 
A
. 
c
a
s
te
lla
n
ii 
c
e
lls
 a
t 
tw
o
 d
if
fe
re
n
t 
ra
ti
o
s
 (
c
ir
c
le
s
, 
5
0
:5
0
; 
d
ia
m
o
n
d
s
, 
7
5
:2
5
).
 D
, 
in
fe
c
ti
o
n
 w
a
s
 d
o
n
e
 a
s
 
d
e
s
c
ri
b
e
d
 i
n
 B
, 
b
u
t 
A
. 
c
a
s
te
lla
n
ii 
c
e
lls
 w
e
re
 i
n
fe
c
te
d
 w
it
h
 b
o
th
 s
tr
a
in
s
 (
W
T
 a
n
d
 Δ
z
w
f)
 a
t 
th
e
 s
a
m
e
 t
im
e
 (
in
 c
o
m
p
e
ti
ti
o
n
).
 A
t 
v
a
ri
o
u
s
 t
im
e
 p
o
in
ts
 p
o
s
ti
n
o
c
u
la
ti
o
n
, 
b
a
c
te
ri
a
 w
e
re
 q
u
a
n
ti
ta
te
d
 b
y
 p
la
ti
n
g
 a
liq
u
o
ts
 o
n
 B
C
Y
E
 a
g
a
r 
(s
e
e
 “
E
x
p
e
ri
m
e
n
ta
l 
P
ro
c
e
d
u
re
s
”)
. 
R
e
s
u
lt
s
 a
re
 m
e
a
n
s
 ±
 S
.D
. 
o
f 
d
u
p
li
c
a
te
 s
a
m
p
le
s
 a
n
d
 a
re
 
re
p
re
s
e
n
ta
ti
v
e
 o
f 
a
t 
le
a
s
t 
th
re
e
 i
n
d
e
p
e
n
d
e
n
t 
e
x
p
e
ri
m
e
n
ts
. 
